Loading
Latest filing published 03 Sept 2026 for Beta Bionics, Inc., €73k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael R. Mensinger appears in our data through filings on Beta Bionics, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 2 June 2026 and the latest from 2 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 3 September 2026, the filings show a transaction worth €73k in Beta Bionics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations